Share This Article:

Use of metformin during pregnancy for women with polycystic ovary syndrome

Abstract Full-Text HTML XML Download Download as PDF (Size:69KB) PP. 111-115
DOI: 10.4236/ojog.2013.31021    6,196 Downloads   8,623 Views   Citations
Author(s)    Leave a comment

ABSTRACT

Objective: The purpose of this article is to review the literature assessing foetal and maternal pregnancy outcomes in women with PCOS who used metformin during pregnancy. Study Design: A literature search was conducted using MEDLINE, with analysis of 25 studies that recorded neonatal and maternal outcomes in women who used metformin during pregnancy. The outcomes assessed in this review include congenital deformities, miscarriages, preterm labour, gestational diabetes (GDM) and pregnancy induced hypertension (PIH). Results: We found that the use of metformin throughout pregnancy correlated with decreased rates of preterm labour, GDM and PIH. Conflicting evidence exists over whether metformin use during pregnancy reduced miscarriage rates. The use of metformin during pregnancy did not increase teratogenicity risks. Conclusion: The use of metformin throughout pregnancy is associated with decreased rates of preterm labour, GDM, and PIH. However, more randomised controls involving larger numbers of participants are required for more definitive results.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Fan, H. (2013) Use of metformin during pregnancy for women with polycystic ovary syndrome. Open Journal of Obstetrics and Gynecology, 3, 111-115. doi: 10.4236/ojog.2013.31021.

References

[1] Rotterdam, E.A.S.P.C.W.G. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility & Sterility, 81, 19-25. doi:10.1016/j.fertnstert.2003.10.004
[2] Roos, N., Kieler, H., Sahlin, L., Ekman-Ordeberg, G., Falconer, H. and Stephansson, O. (2011) Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: Population based cohort study. British Medical Journal, 343, Article ID: d6309. doi:10.1136/bmj.d6309
[3] Iavazzo, C. and Vitoratos, N. (2010) Polycystic ovarian syndrome and pregnancy outcome. Archives of Gynecology & Obstetrics, 282, 235-239. doi:10.1007/s00404-010-1495-0
[4] Kjerulff, L.E., Sanchez-Ramos, L. and Duffy, D. (2011) Pregnancy outcomes in women with polycystic ovary syndrome: A metaanalysis. American Journal of Obstetrics & Gynecology, 204, 558.e1-558e6.
[5] Sirtori, C.R. and Pasik, C. (1994) Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacological Research, 30, 187-228. doi:10.1016/1043-6618(94)80104-5
[6] Garber, A.J., Duncan, T.G., Goodman, A.M., Mills, D.J. and Rohlf, J.L. (1997) Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial. American Journal of Medicine, 103, 491-497. doi:10.1016/S0002-9343(97)00254-4
[7] Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E. and Muggeo, M. (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. Journal of Clinical Endocrinology & Metabolism, 85, 139-146. doi:10.1210/jc.85.1.139
[8] Creanga, A.A., Bradley, H.M., McCormick, C. and Witkop, C.T. (2008) Use of metformin in polycystic ovary syndrome: A meta-analysis. Obstetrics & Gynecology, 111, 959-968. doi:10.1097/AOG.0b013e31816a4ed4
[9] Tang, T., Lord, J.M., Norman, R.J., Yasmin, E. and Balen, A.H. (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews, 5, Article ID: CD003053.
[10] Begum, M.R., Khanam, N.N., Quadir, E., Ferdous, J., Begum, M.S., Khan, F. and Begum, A. (2009) Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. Journal of Obstetrics & Gynaecology Research, 35, 282-286. doi:10.1111/j.1447-0756.2008.00876.x
[11] Morin-Papunen, L., Rantala, A.S., Unkila-Kallio, L., Tiitinen, A., Hippelainen, M., Perheentupa, A., Tinkanen, H., Bloigu, R., Puukka, K., Ruokonen, A. and Tapanainen, J.S. (2012) Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): A multicenter, double-blind, placebo-controlled randomized trial. Journal of Clinical Endocrinology & Metabolism, 97, 1492-500. doi:10.1210/jc.2011-3061
[12] Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogoy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K.F., Bunford, G., Lund, A., Bjerke, C., Almas, I., Berg, A.H., Danielson, A., Lahmami, G. and Carlsen, S.M. (2010) Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: A randomized, controlled multicenter study. Journal of Clinical Endocrinology & Metabolism, 95, E448-E455. doi:10.1210/jc.2010-0853
[13] Salvesen, K.A., Vanky, E. and Carlsen, S.M. (2007) Metformin treatment in pregnant women with polycystic ovary syndrome—Is reduced complication rate mediated by changes in the uteroplacental circulation? Ultrasound in Obstetrics & Gynecology, 29, 433-437. doi:10.1002/uog.3965
[14] Sohrabvand, F., Shariat, M., Haghollahi, F. and Bagheri, B. (2009) Effect of metformin on miscarriage in pregnant patients with polycystic ovary syndrome. West Indian Medical Journal, 58, 433-436.
[15] Nawaz, F.H. and Rizvi, J. (2010) Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecologic & Obstetric Investigation, 69, 184-189. doi:10.1159/000268051
[16] Bolton, S., Cleary, B., Walsh, J., Dempsey, E. and Turner, M.J. (2009) Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. European Journal of Pediatrics, 168, 203-206. doi:10.1007/s00431-008-0737-7
[17] Thatcher, S.S. and Jackson, E.M. (2006) Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertility & Sterility, 85, 1002-1009. doi:10.1016/j.fertnstert.2005.09.047
[18] Jakubowicz, D.J., Iuorno, M.J., Jakubowicz, S., Roberts, K.A. and Nestler, J.E. (2002) Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 87, 524-529. doi:10.1210/jc.87.2.524
[19] Ramidi, G., Khan, N., Glueck, C.J., Wang, P. and Goldenberg, N. (2009) Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss. Translational Research: The Journal of Laboratory & Clinical Medicine, 153, 33-43. doi:10.1016/j.trsl.2008.11.003
[20] De Leo, V., Musacchio, M.C., Piomboni, P., Di Sabatino, A. and Morgante, G. (2011) The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. European Journal of Obstetrics, Gynecology, & Reproductive Biology, 157, 63-66. doi:10.1016/j.ejogrb.2011.03.024
[21] Khattab, S., Mohsen, I.A., Aboul Foutouh, I., Ashmawi, H.S., Mohsen, M.N., van Wely, M., van der Veen, F. and Youssef, M.A. (2011) Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecological Endocrinology, 27, 789-793. doi:10.3109/09513590.2010.540600
[22] Glueck, C.J., Pranikoff, J., Aregawi, D. and Wang, P. (2008) Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertility & Sterility, 89, 625-634. doi:10.1016/j.fertnstert.2007.03.036
[23] Nawaz, F.H., Khalid, R., Naru, T. and Rizvi, J. (2008) Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? Journal of Obstetrics & Gynaecology Research, 34, 832-837. doi:10.1111/j.1447-0756.2008.00856.x
[24] Glueck, C.J., Salehi, M., Sieve, L. and Wang, P. (2006) Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome. Journal of Pediatrics, 148, 628-632. doi:10.1016/j.jpeds.2006.01.011
[25] Khattab, S., Mohsen, I.A., Foutouh, I.A., Ramadan, A., Moaz, M. and Al-Inany, H. (2006) Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecological Endocrinology, 22, 680-4. doi:10.1080/09513590601010508
[26] Kovo, M., Weissman, A., Gur, D., Levran, D., Rotmensch, S. and Glezerman, M. (2006) Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy. Journal of Maternal-Fetal & Neonatal Medicine, 19, 415-419. doi:10.1080/14767050600682370
[27] Turner, M.J., Walsh, J., Byrne, K.M., Murphy, C., Langan, H. and Farah, N. (2006) Outcome of clinical pregnancies after ovulation induction using metformin. Journal of Obstetrics & Gynaecology, 26, 233-235. doi:10.1080/01443610600555295
[28] Glueck, C.J., Wang, P., Goldenberg, N. and Sieve, L. (2004) Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin. Clinical & Applied Thrombosis/Hemostasis, 10, 323-334. doi:10.1177/107602960401000404
[29] Glueck, C.J., Goldenberg, N., Wang, P., Loftspring, M. and Sherman, A. (2004) Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Human Reproduction, 19, 510-521. doi:10.1093/humrep/deh109
[30] Glueck, C.J., Goldenberg, N., Pranikoff, J., Loftspring, M., Sieve, L. and Wang, P. (2004) Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human Reproduction, 19, 1323-1330. doi:10.1093/humrep/deh263
[31] Glueck, C.J., Bornovali, S., Pranikoff, J., Goldenberg, N., Dharashivkar, S. and Wang, P. (2004) Metformin, preeclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabetic Medicine, 21, 829-836. doi:10.1111/j.1464-5491.2004.01251.x
[32] Glueck, C.J., Wang, P., Kobayashi, S., Phillips, H. and Sieve-Smith, L. (2002) Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertility & Sterility, 77, 520-525. doi:10.1016/S0015-0282(01)03202-2
[33] Glueck, C.J., Wang, P., Goldenberg, N. and Sieve-Smith, L. (2002) Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human Reproduction, 17, 2858-2864. doi:10.1093/humrep/17.11.2858
[34] Glueck, C.J., Phillips, H., Cameron, D., Sieve-Smith, L. and Wang, P. (2001) Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study. Fertility & Sterility, 75, 46-52. doi:10.1016/S0015-0282(00)01666-6
[35] Rowan, J.A., Hague, W.M., Gao, W., Battin, M.R., Moore, M.P. and Mi, G.T.I. (2008) Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine, 358, 2003-2015. doi:10.1056/NEJMoa0707193
[36] Moore, L.E., Briery, C.M., Clokey, D., Martin, R.W., Williford, N.J., Bofill, J.A. and Morrison, J.C. (2007) Metformin and insulin in the management of gestational diabetes mellitus: Preliminary results of a comparison. Journal of Reproductive Medicine, 52, 1011-1015.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.